New Motor Vehicle Board by Archer, T. L.
REGULATORY AGENCY ACTION 
awarded the human drug testing contract 
to PharmChem Laboratories, which had 
submitted the only bid for that contract. 
At its September 23 meeting, CHRB 
elected Ralph Scurfield to serve as Board 
Chair, and Donald Valpredo to serve as 
Vice-Chair. 
■ FUTURE MEETINGS 
January 29 in Monrovia. 
February 26 in Arcadia. 
March 26 in Berkeley. 
April 30 in Arcadia. 
NEW MOTOR VEHICLE 
BOARD 
Executive Officer: 
Sam W. Jennings 
(916) 445-1888 
Pursuant to Vehicle Code section 3000 et seq., the New Motor Vehicle Board 
(NMVB) licenses new motor vehicle 
dealerships and regulates dealership 
relocations and manufacturer termina-
tions of franchises. It reviews disciplinary 
action taken against dealers by the Depart-
ment of Motor Vehicles (DMV). Most 
licensees deal in cars or motorcycles. 
NMVB is authorized to adopt regula-
tions to implement its enabling legisla-
tion; the Board's regulations are codified 
in Chapter 2, Division I, Title 13 of the 
California Code of Regulations (CCR). 
The Board also handles disputes arising 
out of warranty reimbursement schedules. 
After servicing or replacing parts in a car 
under warranty, a dealer is reimbursed by 
the manufacturer. The manufacturer sets 
reimbursement rates which a dealer oc-
casionally challenges as unreasonable. In-
frequently, the manufacturer's failure to 
compensate the dealer for tests performed 
on vehicles is questioned. 
The Board consists of four dealer 
members and five public members. The 
Board's staff consists of an executive 
secretary, three legal assistants and two 
secretaries. 
■ MAJOR PROJECTS 
Board Permits Termination of 
Franchise. At its July 24 meeting, NMVB 
considered a protest filed by Jim Lynch 
Cadillac, Inc., against General Motors 
Corporation's (GMC) Cadillac Motor Car 
Division, following GMC's October 1991 
decision to terminate the Cadillac 
franchise held by Lynch. In considering 
the protest, NMVB noted that Vehicle 
Code section 3066 imposes upon GMC 
the burden of establishing the existence of 
good cause to terminate or refuse to con-
tinue Lynch's franchise. In determining 
whether good cause has been established, 
Vehicle Code section 3061 requires 
NMVB to consider the amount of business 
transacted by the franchisee, as compared 
to the business available to the franchisee; 
any investment necessarily made and 
obligations incurred by the franchisee to 
perform its part of the franchise; the per-
manency of the investment; whether it is 
injurious or beneficial to the public wel-
fare for the franchise to be modified or 
replaced or the business of the franchisee 
disrupted; whether the franchisee has ade-
quate motor vehicle sales and service 
facilities, equipment, vehicle parts, and 
qualified service personnel to reasonably 
provide for the needs of the consumers for 
the motor vehicles handled by the 
franchisee and has been and is rendering 
adequate services to the public; whether 
the franchisee has failed to fulfill the war-
ranty obligations of the franchisor to be 
performed by the franchisee; and the ex-
tent of the franchisee's failure to comply 
with the terms of the franchise. 
According to GMC, good cause ex-
isted to terminate Lynch's franchise be-
cause of Lynch's breach of the terms of the 
franchise. According to GMC, Lynch 
breached its Dealer Agreement by aban-
doning its sales facility located on La Brea 
Avenue in Inglewood, and consolidating 
its new car sales operation at an unap-
proved and unauthorized service location 
on Centinela Avenue in Inglewood. Lynch 
contended that it had been attempting for 
five years to find possible sites for the 
relocation of the dealership, and that the 
Centinela location was merely a tem-
porary arrangement while it continued to 
pursue efforts to relocate. Lynch also con-
tended that the consolidation was justified 
because continued operations from both 
facilities would have resulted in Lynch's 
insolvency. 
After reviewing the available data, 
NMVB made the following findings: 
-In light of the sufficient opportunity 
for Cadillac sales within Lynch's area of 
geographic sales and service, Lynch has 
been "weak and marginal as a Cadillac 
dealer." 
-Of the $2.775 million acquisition 
price, only $ I 60,000 qualifies as Lynch's 
permanent investment. 
-The public is inconvenienced and 
Cadillac's image and standards are 
diminished by the fact that there is no 
showroom for new vehicles at the Cen-
tinela facility; new and used car sales are 
conducted out of two mobile home-type 
trailers located in the parking lot; the 
facility is crowded and new car customers 
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must first go through the service area 
before they get to the area where the new 
cars are located. 
-The Centinela facility has only 17.3% 
of the space required by GM C's space and 
facilities guidelines and is therefore defi-
cient under those guidelines. 
-Lynch's decision to consolidate was 
precipitated by the expiration of its lease 
at the La Brea location and its desire to 
reduce its monthly losses. 
-Lynch's fiscal condition does not jus-
tify an unauthorized relocation of its sales 
operations. 
Accordingly, NMVB concluded that 
Lynch breached its Dealer Agreement by 
unilaterally moving its new car sales 
operations from the approved location to 
an unauthorized location, and to the extent 
that the unauthorized relocation resulted 
in inadequate facilities which are far 
below the facilities and space guidelines 
required under the Dealer Agreement. As 
a result, NMVB held that GMC is per-
mitted to terminate the franchise of Jim 
Lynch Cadillac. 
Board Settles Warranty Debate. In 
November 1991, Quaid Imports, Inc., a 
Maserati franchisee since 1983, filed peti-
tion number P-230-91 with NMVB, seek-
ing damages and declaratory relief on its 
claim that Maserati Automobiles, Inc. 
(Maserati) had refused to reimburse Quaid 
for warranty repairs made to a certain 
1989 Maserati automobile. Pursuant to an 
April 1990 settlement agreement reached 
by the parties in an unrelated matter, 
Maserati had delivered a new Maserati to 
Quaid and agreed that Quaid would retain 
"the two new Maserati automobiles cur-
re n ti y in its possession"; the 1989 
Maserati at issue in Quaid's November 
l 991 petition was one of the "new 
Maserati automobiles" referred to in the 
Aprill 1990 settlement agreement. 
Pursuant to Maserati's Standard 
Dealer Agreement, Quaid was required to 
maintain at least one demonstrator avail-
able at all times. On November 22, 1988, 
the date of deli very of the l 989 Maserati, 
Quaid informed his inventory manager 
that he would use that automobile as his 
demonstrator; the manager immediately 
filed a Demonstrator Report Card with 
Maserati, as required by the Agreement. 
Under the terms of Maserati's 1989 model 
year warranty, the coverage period could 
start either on the date of retail delivery to 
a customer or upon first use as a 
demonstrator or company car; the total 
term of the warranty was three years or 
36,000 miles, whichever came first. 
Maserati was to administer the coverage 
for the first two years or 24,000 miles 
directly, and the third year of extended 
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coverage was provided through Maryland 
Casualty. 
Quaid only drove the vehicle once, and 
changed his mind about using the car as a 
demonstrator; however, he did allow the 
car to be test-driven by prospective pur-
chasers. In October 1990, Quaid informed 
Maserati that the Demonstrator Report 
Card was filed in error and that he had not 
actually used the car as a demonstrator. In 
March 1991, Quaid discovered that the 
car's battery was dead; he replaced the 
battery and filed a claim for reimburse-
ment with Maserati. In May 1991, 
Maserati rejected the claim, contending 
that the vehicle's factory warranty term 
had begun to run on November 22, 1988, 
and that the two-year factory warranty had 
expired. In September 1991, the vehicle 
was sold to a customer who was told that 
the vehicle was a new vehicle with 340 
miles on the odometer. Within a month, 
the customer had returned the vehicle for 
repairs totalling $499.81; that claim was 
also rejected by Maserati, which again 
contended that the two-year factory war-
ranty had expired. 
Because the April 1990 settlement 
agreement in the separate matter referred 
to the Maserati in question as "new," 
Quaid contended that the warranty period 
on the subject vehicle had not actually 
commenced. Because the word "new," as 
it appears in the settlement agreement with 
reference to the subject vehicle, is 
reasonably susceptible to more than one 
meaning, NMVB allowed parol evidence 
to determine whether the parties intended 
that the vehicle would be retained by 
Quaid with a full 36-month warranty or 
with 28 months of warranty coverage al-
ready expired. After reviewing the 
evidence presented to it, NMVB con-
cluded that in the context of the settlement 
agreement, the word "new" was meant to 
designate those vehicles which Quaid 
would retain for retail sale to the public; it 
did not mean that the status of the subject 
vehicle was changed from "demonstrator" 
to "new vehicle" for the purpose of war-
ranty. Thus, NMVB concluded that 
Maserati's coverage ended on November 
22, 1990; any obligation for warranty 
claims during the third year of warranty 
coverage is the responsibility of Maryland 
Casualty. 
■ LEGISLATION 
AB 126 (Moore) would have enacted 
the "One-Day Cancellation Law" which 
would have provided that, in addition to 
any other right to revoke an offer or re-
scind a contract, the buyer of a motor 
vehicle has the right to cancel a motor 
vehicle contract or offer which complies 
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with specified requirements until the close 
of business of the first business day after 
the day on which the buyer signed the 
contract or offer. This bill died in commit-
tee. 
■ FUTURE MEETINGS 
To be announced. 
OSTEOPATHIC 





In 1922, California voters approved a constitutional initiative which created 
the Board of Osteopathic Examiners; 
199 I legislation changed the Board's 
name to the Osteopathic Medical Board of 
California (OMBC). Today, pursuant to 
Business and Professions Code section 
3600 et seq., OMBC regulates entry into 
the osteopathic profession, examines and 
approves schools and colleges of os-
teopathic medicine, and enforces profes-
sional standards. The Board is empowered 
to adopt regulations to implement its ena-
bling legislation; OMBC's regulations are 
codified in Division 16, Title 16 of the 
California Code of Regulations (CCR). 
The 1922 initiative, which provided for a 
five-member Board consisting of practic-
ing doctors of osteopathy (DOs), was 
amended in 1982 to include two public 
members. The Board now consists of 
seven members, appointed by the Gover-
nor, serving staggered three-year terms. 
The Board is presently awaiting 
Governor Wilson's appointment of three 
new members (two DOs and one public 
member). 
■ MAJOR PROJECTS 
Governor Upholds OAL Rejection 
of Medical Board's Training Program 
Regulation. On June 11, Governor Wil-
son upheld the Office of Administrative 
Law's (OAL) rejection of the Medical 
Board of California's (MBC) adoption of 
section I 325.5, Division 13, Title 16 of the 
CCR, as being discriminatory against os-
teopathic physicians. 
Under regulatory section 1324, MBC's 
Division of Licensing (DOL) is 
authorized to approve alternative clinical 
training programs for foreign medical 
graduates who have difficulty obtaining a 
postgraduate training program approved 
by the Accreditation Council on Graduate 
Medical Education of the American Medi-
cal Association. DOL recently adopted 
new section 1325.5, which would have 
required the medical director of a section 
1324 training program to have an MD 
degree. The Division insisted on this 
provision over numerous objections that it 
violates Busi:1ess and Professions Code 
section 2453, which prohibits discrimina-
tion between MDs and osteopathic 
physicians (DOs) on the basis of the de-
gree. OAL rejected the provision three 
times, and DOL appealed the rejection to 
the Governor shortly after its May 7 meet-
ing. [12:2&3 CRLR 102,256] 
On June 11, the Governor upheld 
OAL's rejection of the MD requirement, 
recognizing the "hundred years war" be-
tween the allopathic and osteopathic 
branches of the medical profession and 
noting that "[t]he California Legislature 
has mandated equality between holders of 
MD degrees (medical doctors) and 
holders of DO degrees (doctors of os-
teopathy) ... .In this state osteopathy is 
firmly established as 'the practice of 
medicine.'" The Governor noted that 
DOL, in its final statement of reasons on 
its proposed rulemaking, stated that the 
proposed restriction ""does not prevent an 
osteopathic physician from being a staff 
teacher'; it applies only to the director. 
Thus, the Board explicitly acknowledges 
that the subject matter to be taught does 
not specifically require an allopathic 
orientation." 
■ LEGISLATION 
AB 2944 (Brulte). Existing law estab-
lishes a state medical contract program 
with accredited medical schools and 
programs that train, among others, 
primary care physician assistants (PAs) 
and primary care nurse practitioners (NPs) 
to maximize the delivery of primary care 
family physician services to specific areas 
of California where there is a recognized 
unmet priority need for these services. 
Existing law requires the Health Man-
power Policy Commission to establish 
standards for family practice training 
programs, family practice residency 
programs, and programs that train primary 
care PAs and primary care NPs. Existing 
law further requires the Commission to 
review and make recommendations to the 
Director of the Office of Statewide Health 
Planning and Development concerning 
the funding of those programs. As 
amended June 26, this bill requires the 
Commission to also establish standards 
for postgraduate osteopathic medical 
programs in family practice. The bill also 
defines "family practice" for these pur-
poses as including the general practice of 
medicine by osteopathic physicians. The 
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